CareView Communications (CRVW) Liabilities and Shareholders Equity (2010 - 2026)
CareView Communications' (CRVW) quarterly Liabilities and Shareholders Equity came in at $5.9 million in Q2 2026, up 6.73% year-over-year from $5.5 million in Q2 2025, and up 23.04% quarter-over-quarter from $4.8 million in Q1 2026.
Analysis
CareView Communications (CRVW) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
CareView Communications has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $5.9 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 6.73% year-over-year to $5.9 million; the TTM figure through Jun 2026 stood at $20.3 million (up 18.01% YoY), while the FY2025 annual figure was $4.6 million, up 28.14% from the prior year.
- Liabilities and Shareholders Equity came in at $5.9 million for Q2 2026 at CareView Communications, up from $4.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $5.9 million in Q2 2026 to a low of $3.6 million in Q4 2024.
- Average Liabilities and Shareholders Equity over 5 years is $4.6 million, with a median of $4.6 million recorded in 2025.
- Year-over-year, Liabilities and Shareholders Equity slipped 26.94% in 2022 and increased 28.14% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $3.9 million in 2022, then rose by 7.97% to $4.3 million in 2023, then fell by 15.03% to $3.6 million in 2024, then rose by 28.14% to $4.6 million in 2025, then grew by 27.03% to $5.9 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $5.9 million in Q2 2026, $4.8 million in Q1 2026, and $4.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 8.97 Bn |
| 10 | CareView Communications | 23.36 Mn | 21.44 Mn | - | 5.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.90 Mn |
| Mar 31, 2026 | 4.79 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | 5.52 Mn |
| Mar 31, 2025 | 3.91 Mn |
| Dec 31, 2024 | 3.62 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Dec 31, 2023 | 4.26 Mn |
| Sep 30, 2023 | 4.78 Mn |
| Jun 30, 2023 | 5.08 Mn |
| Mar 31, 2023 | 4.04 Mn |
| Dec 31, 2022 | 3.95 Mn |
| Sep 30, 2022 | 4.02 Mn |
| Jun 30, 2022 | 4.39 Mn |
| Mar 31, 2022 | 5.01 Mn |
| Dec 31, 2021 | 5.08 Mn |
| Sep 30, 2021 | 5.50 Mn |
| Jun 30, 2021 | 5.20 Mn |